---
figid: PMC7180799__molecules-25-01529-g006
figtitle: Proposed signaling pathways for the protective effect of LPA against simvastatin-induced
  cytotoxicity in L6 cells
organisms:
- NA
pmcid: PMC7180799
filename: molecules-25-01529-g006.jpg
figlink: pmc/articles/PMC7180799/figure/molecules-25-01529-f006/
number: F6
caption: Proposed signaling pathways for the protective effect of LPA against simvastatin-induced
  cytotoxicity in L6 cells. LPA receptor activation by LPA may influence PKC/ERK1/2,
  PLC/intracellular Ca2+ mobilization, and mTOR/AKT pathways, leading to cell survival.
  Such cell survival effect may result in inhibition of simvastatin-induced cytotoxicity
  in L6 cells. LPA, lysophosphatidic acid; PKC, protein kinase C; PLC, phospholipase
  C; ERK1/2, Extracellular signal-regulated kinase 1/2; mTOR, mammalian target of
  rapamycin; PI3K, Phosphoinositide 3-kinases; Akt, Protein kinase B; Bad, Bcl-2 associated
  agonist of cell death; Bax, Bcl-2-associated X protein; Bcl-2, B-cell lymphoma 2.
papertitle: Lysophosphatidic Acid Inhibits Simvastatin-Induced Myocytoxicity by Activating
  LPA Receptor/PKC Pathway.
reftext: Kyung-Jong Won, et al. Molecules. 2020 Apr;25(7):1529.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9592644
figid_alias: PMC7180799__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7180799__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7180799__molecules-25-01529-g006.html
  '@type': Dataset
  description: Proposed signaling pathways for the protective effect of LPA against
    simvastatin-induced cytotoxicity in L6 cells. LPA receptor activation by LPA may
    influence PKC/ERK1/2, PLC/intracellular Ca2+ mobilization, and mTOR/AKT pathways,
    leading to cell survival. Such cell survival effect may result in inhibition of
    simvastatin-induced cytotoxicity in L6 cells. LPA, lysophosphatidic acid; PKC,
    protein kinase C; PLC, phospholipase C; ERK1/2, Extracellular signal-regulated
    kinase 1/2; mTOR, mammalian target of rapamycin; PI3K, Phosphoinositide 3-kinases;
    Akt, Protein kinase B; Bad, Bcl-2 associated agonist of cell death; Bax, Bcl-2-associated
    X protein; Bcl-2, B-cell lymphoma 2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LPA
  - PC
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - BAD
  - BCL2
  - MAPK3
  - MAPK1
  - DST
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - LPA
  - LY294002
  - Simvastatin
  - Rapamycin
  - PD98059
  - Ca2+
---
